January 12-15 | San Francisco Marriott Marquis
January 12-16 | Virtual
Laurent Pharmaceuticals
Developing the first pan-macular degeneration therapy (Phase 2 ready). We are attending BIOPartnering to explore investment and/or partnership opportunities for our technology.